| Physiology of penile erection KE Andersson, G Wagner Physiological reviews 75 (1), 191-236, 1995 | 1392 | 1995 |
| Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ … P Abrams, KE Andersson, L Birder, L Brubaker, L Cardozo, C Chapple, ... Neurourology and Urodynamics: Official Journal of the International …, 2010 | 1242* | 2010 |
| Urinary bladder contraction and relaxation: physiology and pathophysiology KE Andersson, A Arner Physiological reviews 84 (3), 935-986, 2004 | 894 | 2004 |
| Pharmacology of the lower urinary tract KE Andersson, C Gratzke Textbook of the neurogenic bladder, 95-114, 2008 | 879 | 2008 |
| Pharmacology of penile erection KE Andersson Pharmacological reviews 53 (3), 417-450, 2001 | 615 | 2001 |
| Defective smooth muscle regulation in cGMP kinase I‐deficient mice A Pfeifer, P Klatt, S Massberg, L Ny, M Sausbier, C Hirneiß, GX Wang, ... The EMBO journal 17 (11), 3045-3051, 1998 | 578 | 1998 |
| The pharmacological treatment of urinary incontinence KE Andersson, R Appell, LD Cardozo, C Chapple, HP Drutz, ... BJU international 84, 923-947, 1999 | 514 | 1999 |
| Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence KE Andersson, AJ Wein Pharmacological reviews 56 (4), 581-631, 2004 | 508 | 2004 |
| Antimuscarinics for treatment of overactive bladder KE Andersson The Lancet Neurology 3 (1), 46-53, 2004 | 485 | 2004 |
| Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder P Abrams, KE Andersson, JJ Buccafusco, C Chapple, WC De Groat, ... British journal of pharmacology 148 (5), 565-578, 2006 | 474 | 2006 |
| Summary of the recommendations on sexual dysfunctions in men TF Lue, F Giuliano, F Montorsi, RC Rosen, KE Andersson, S Althof, ... The journal of sexual medicine 1 (1), 6-23, 2004 | 459 | 2004 |
| EAU guidelines on urinary incontinence JW Thüroff, P Abrams, KE Andersson, W Artibani, CR Chapple, MJ Drake, ... Actas Urológicas Españolas (English Edition) 35 (7), 373-388, 2011 | 447 | 2011 |
| Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels ED Högestätt, KE Andersson, L Edvinsson Acta Physiologica Scandinavica 117 (1), 49-61, 1983 | 430 | 1983 |
| Muscarinic receptor antagonists for overactive bladder P Abrams, KE Andersson BJU international 100 (5), 987-1006, 2007 | 407 | 2007 |
| Bladder activation: afferent mechanisms KE Andersson Urology 59 (5), 43-50, 2002 | 405 | 2002 |
| Tolterodine–a new bladder-selective antimuscarinic agent L Nilvebrant, KE Andersson, PG Gillberg, M Stahl, B Sparf European journal of pharmacology 327 (2-3), 195-207, 1997 | 388 | 1997 |
| The vasodilator‐stimulated phosphoprotein (VASP) is involved in cGMP‐and cAMP‐mediated inhibition of agonist‐induced platelet aggregation, but is dispensable for smooth muscle … A Aszódi, A Pfeifer, M Ahmad, M Glauner, XH Zhou, L Ny, KE Andersson, ... The EMBO journal 18 (1), 37-48, 1999 | 371 | 1999 |
| Factors maintaining the intraurethral pressure in women. T Rud, KE Andersson, M Asmussen, A Hunting, U Ulmsten Investigative urology 17 (4), 343-347, 1980 | 346 | 1980 |
| Internet use and Problematic Internet Use: A systematic review of longitudinal research trends in adolescence and emergent adulthood EL Anderson, E Steen, V Stavropoulos International Journal of Adolescence and Youth 22 (4), 430-454, 2017 | 328* | 2017 |
| Antimuscarinics and the overactive detrusor—which is the main mechanism of action? KE Andersson, M Yoshida European urology 43 (1), 1-5, 2003 | 328 | 2003 |